GLIMCOD 1 GLIMEPIRIDE 1mg. IP

Glimcod 1 tablets carry Glimepiride 1 mg and are used alongside diet and exercise for glycaemic control in adults with type 2 diabetes. Main uses: adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus; stimulates insulin release from the pancreas, helping lower blood glucose.

Common side effects of Glimcod 1 Tablet include low blood glucose (hypoglycaemia); dizziness; weakness or tiredness (asthenia); headache; nausea. Get medical help at once if you notice severe hypoglycaemia; serious allergic reactions such as anaphylaxis, angioedema and Stevens-Johnson syndrome; haemolytic anaemia in patients with G6PD deficiency.

Each Glimcod 1 tablet contains Glimepiride 1 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Glimcod 1 Tablet only as your doctor advises.

The MRP of Glimcod 1 Tablet is ₹39.69 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹30.24 and the PTS is ₹27.22.

Each Glimcod 1 tablet contains Glimepiride 1 mg. It comes in a pack of 10x10 (Blister).

The ingredient Glimepiride acts by closing ATP-sensitive potassium channels on the pancreatic beta cells, which encourages the release of insulin. Once released, insulin helps the body take up sugar from the blood into the cells, and this brings blood glucose levels lower.

Must not be used for type 1 diabetes mellitus. Must not be used for diabetic ketoacidosis. Must not be used by anyone allergic to glimepiride or to any ingredient of the tablet. Must not be used by anyone who has had an allergic reaction to sulfonamide derivatives. Check with a doctor first if you are elderly, have kidney impairment, have G6PD deficiency, or are taking other anti-diabetic medicines.

Glimcod 1 Tablet is a brand of Vibcare Pharma, sold through its Medanor division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.